PLA2R1 and nephrotic syndrome: Currently, general treatment for PLA2R-associated PMN patients includes the use of diuretics, angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin-receptor blockers (ARBs), statins, anticoagulants, and vitamin D to alleviate the symptoms and reduce the complications associated with nephrotic syndrome.